Maxcyte logo

Maxcyte share price today

(MXCT)

Maxcyte share price is $4.3 & ₹368.98 as on 7 Jan 2025, 2.30 'hrs' IST

$4.3

-0.09

(-2.05%)

Market is closed - opens 8 PM, 07 Jan 2025

View live Maxcyte share price in Dollar and Rupees. Guide to invest in Maxcyte stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Maxcyte, along with analyst recommendations, forecasts, and comprehensive financials.

Maxcyte share price movements

  • Today's Low: $4.25
    Today's High: $4.48

    Day's Volatility :5.13%

  • 52 Weeks Low: $3.17
    52 Weeks High: $5.55

    52 Weeks Volatility :42.92%

Maxcyte Returns

PeriodMaxcyte IncSector (Health Care)Index (Russel 2000)
3 Months
13.14%
-8.4%
0.0%
6 Months
5.02%
-3.8%
0.0%
1 Year
-4.36%
-0.1%
0.0%
3 Years
-49.01%
2.9%
-19.8%

Maxcyte Key Statistics

in dollars & INR

Previous Close
$4.39
Open
$4.4
Today's High
$4.48
Today's Low
$4.25
Market Capitalization
$438.8M
Today's Volume
$287.9K
52 Week High
$5.545
52 Week Low
$3.165
Revenue TTM
$45.6M
EBITDA
$-42.0M
Earnings Per Share (EPS)
$-0.34
Profit Margin
-78.37%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-16.0%

How to invest in Maxcyte from India?

It is very easy for Indian residents to invest directly in Maxcyte from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Maxcyte stock in both Indian Rupees (INR) and US Dollars (USD). Search for Maxcyte or MXCT on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Maxcyte or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Maxcyte shares which would translate to 0.200 fractional shares of Maxcyte as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Maxcyte, in just a few clicks!

Returns in Maxcyte for Indian investors in Rupees

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Maxcyte investment value today

Current value as on today

₹96,905

Returns

₹3,095

(-3.1%)

Returns from Maxcyte Stock

₹6,318 (-6.32%)

Dollar Returns

₹3,223 (+3.22%)

Indian investors sentiment towards Maxcyte

63%

Period: Oct 8, 2024 to Jan 6, 2025. Change in 30 Days versus previous period

Search volume for Maxcyte on INDmoney from India has grown in the last 30 days as on Jan 7, 2025. 63% more investors are searching Maxcyte in the last 30 days versus the previous period.

Global Institutional Holdings in Maxcyte

  • Cadian Capital Management LP

    7.76%

  • BlackRock Inc

    7.72%

  • Vanguard Group Inc

    5.48%

  • Vitruvian Partners

    4.78%

  • Morgan Stanley - Brokerage Accounts

    4.57%

  • Millennium Management LLC

    3.97%

Analyst Recommendation on Maxcyte

Buy

    92%Buy

    7%Hold

    0%Sell

Based on 13 Wall street analysts offering stock ratings for Maxcyte(by analysts ranked 0 to 5 stars)

Based on 13 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
12
12
12
Hold
1
1
1
Sell
0
0
0

Analyst Forecast on Maxcyte

What analysts predicted

Upside of 101.55%

Current:

$4.30

Target:

$8.67

Insights on Maxcyte

  • Price Movement

    In the last 1 month, MXCT stock has moved up by 21.9%
  • Decreasing Revenue

    Revenue is down for the last 4 quarters, 15.66M → 8.16M (in $), with an average decrease of 19.1% per quarter
  • Decreasing Net Profit

    Netprofit is down for the last 2 quarters, -9.37M → -11.55M (in $), with an average decrease of 23.3% per quarter
  • MXCT vs BSX (1 yr)

    In the last 1 year, Boston Scientific Corp. has given 55.9% return, outperforming this stock by 60.5%
  • MXCT vs BSX (3 yr)

    In the last 3 years, Boston Scientific Corp. has given 112.9% return, outperforming this stock by 163.7%
  • Price to Sales

    ForMXCT every $1 of sales, investors are willing to pay $10.0, whereas for Boston Scientific Corp., the investors are paying $8.4 for every $1 of sales.

Maxcyte Financials in INR & Dollars

FY18Y/Y Change
Revenue
$16.7M
↑ 19.18%
Net Income
$-8.9M
↓ 10.57%
Net Profit Margin
-53.21%
↑ 17.7%
FY19Y/Y Change
Revenue
$21.6M
↑ 29.72%
Net Income
$-13.6M
↑ 53.07%
Net Profit Margin
-62.79%
↓ 9.58%
FY20Y/Y Change
Revenue
$26.2M
↑ 21.04%
Net Income
$-12.6M
↓ 6.88%
Net Profit Margin
-48.31%
↑ 14.48%
FY21Y/Y Change
Revenue
$33.9M
↑ 29.52%
Net Income
$-20.1M
↑ 59.2%
Net Profit Margin
-59.38%
↓ 11.07%
FY22Y/Y Change
Revenue
$44.3M
↑ 30.59%
Net Income
$-19.8M
↓ 1.72%
Net Profit Margin
-44.69%
↑ 14.69%
FY23Y/Y Change
Revenue
$41.3M
↓ 6.72%
Net Income
$-37.9M
↑ 91.71%
Net Profit Margin
-91.85%
↓ 47.16%
Q2 FY23Q/Q Change
Revenue
$9.0M
↑ 5.44%
Net Income
$-10.5M
↑ 22.43%
Net Profit Margin
-116.25%
↓ 16.14%
Q3 FY23Q/Q Change
Revenue
$8.0M
↓ 11.48%
Net Income
$-11.3M
↑ 7.04%
Net Profit Margin
-140.57%
↓ 24.32%
Q4 FY23Q/Q Change
Revenue
$15.7M
↑ 95.71%
Net Income
$-5.3M
↓ 53.1%
Net Profit Margin
-33.68%
↑ 106.89%
Q1 FY24Q/Q Change
Revenue
$11.3M
↓ 27.6%
Net Income
$-9.5M
↑ 80.52%
Net Profit Margin
-83.99%
↓ 50.31%
Q2 FY24Q/Q Change
Revenue
$10.4M
↓ 8.05%
Net Income
$-9.4M
↓ 1.59%
Net Profit Margin
-89.89%
↓ 5.9%
Q3 FY24Q/Q Change
Revenue
$8.2M
↓ 21.72%
Net Income
$-11.6M
↑ 23.27%
Net Profit Margin
-141.56%
↓ 51.67%
FY18Y/Y Change
Profit
$14.8M
↑ 18.31%
FY19Y/Y Change
Profit
$19.1M
↑ 28.96%
FY20Y/Y Change
Profit
$23.4M
↑ 22.39%
FY21Y/Y Change
Profit
$30.2M
↑ 29.25%
FY22Y/Y Change
Profit
$39.2M
↑ 29.48%
FY23Y/Y Change
Profit
$36.5M
↓ 6.68%
Q2 FY23Q/Q Change
Profit
$7.7M
↑ 1.19%
Q3 FY23Q/Q Change
Profit
$7.2M
↓ 5.95%
Q4 FY23Q/Q Change
Profit
$13.0M
↑ 80.69%
Q1 FY24Q/Q Change
Profit
$8.9M
↓ 31.92%
Q2 FY24Q/Q Change
Profit
$7.9M
↓ 10.87%
Q3 FY24Q/Q Change
Profit
$6.2M
↓ 21.13%
FY18Y/Y Change
Operating Cash Flow
$-10.5M
↑ 8.37%
Investing Cash Flow
$-3.8M
↑ 528.69%
Financing Cash Flow
$226.8K
↓ 99.05%
FY19Y/Y Change
Operating Cash Flow
$-8.8M
↓ 16.07%
Investing Cash Flow
$454.5K
↓ 111.86%
Financing Cash Flow
$12.3M
↑ 5328.04%
FY20Y/Y Change
Operating Cash Flow
$-8.8M
↓ 0.23%
Investing Cash Flow
$-16.6M
↓ 3747.52%
Financing Cash Flow
$28.9M
↑ 134.79%
FY21Y/Y Change
Operating Cash Flow
$-10.7M
↑ 21.61%
Investing Cash Flow
$-195.0M
↑ 1076.34%
Financing Cash Flow
$234.7M
↑ 712.05%
FY22Y/Y Change
Operating Cash Flow
$-14.8M
↑ 38.42%
Investing Cash Flow
$-24.8M
↓ 87.27%
Financing Cash Flow
$2.9M
↓ 98.77%
Q2 FY23Q/Q Change
Operating Cash Flow
$-10.1M
↑ 133.66%
Investing Cash Flow
$26.7M
↓ 10.0%
Financing Cash Flow
$156.7K
↓ 89.24%

Maxcyte Technicals Summary

Sell

Neutral

Buy

Maxcyte is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Maxcyte Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Maxcyte Inc
5.28%
5.02%
-4.36%
-49.01%
-58.03%
Stryker Corporation
-5.14%
7.73%
20.51%
37.02%
70.83%
Boston Scientific Corp.
2.22%
18.53%
55.24%
113.84%
98.4%
Edwards Lifesciences Corp.
4.25%
-20.93%
-2.33%
-38.47%
-5.21%
Abbott Laboratories
-0.93%
11.99%
1.27%
-15.84%
31.69%
Medtronic Plc
-3.59%
5.29%
-6.49%
-23.36%
-31.62%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Maxcyte Inc
NA
NA
NA
-0.41
-0.16
-0.11
NA
2.03
Stryker Corporation
38.59
38.59
2.51
12.06
0.19
0.07
0.01
52.86
Boston Scientific Corp.
73.82
73.82
1.62
2.46
0.09
0.05
NA
14.05
Edwards Lifesciences Corp.
28.0
28.0
6.67
2.54
0.19
0.11
NA
16.18
Abbott Laboratories
34.38
34.38
2.19
4.68
0.15
0.06
0.02
22.94
Medtronic Plc
24.43
24.43
1.46
5.45
0.08
0.04
0.03
38.29
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Maxcyte Inc
Buy
$438.8M
-58.03%
NA
-78.37%
Stryker Corporation
Buy
$137.3B
70.83%
38.59
16.34%
Boston Scientific Corp.
Buy
$131.6B
98.4%
73.82
11.26%
Edwards Lifesciences Corp.
Buy
$43.6B
-5.21%
28.0
65.86%
Abbott Laboratories
Buy
$196.2B
31.69%
34.38
13.99%
Medtronic Plc
Buy
$102.4B
-31.62%
24.43
12.06%

About Maxcyte

MaxCyte is a leading commercial cell-engineering company focused on providing enabling platform technologies to advance innovative cell-based research as well as next-generation cell therapeutic discovery, development and commercialization.
Organization
Maxcyte
Employees
143
CEO
Mr. Maher Masoud
Industry
Healthcare

Management People of Maxcyte

NameTitle
Mr. Maher Masoud
President, CEO & Executive Director
Mr. Douglas Arthur Doerfler
Founder
Mr. Douglas J. Swirsky CFA, CPA
Chief Financial Officer
Mr. Jay Gelfman
Senior Vice President of Operations
Mr. Ronald Evan Holtz CPA, Ph.D.
Executive Vice President of Administration
Mr. David Sandoval
Senior Vice President, General Counsel & Corporate Secretary
Mr. Thomas Michael Ross
Executive Vice President of Global Sales
Mr. Jack Horgan
Vice President of Corporate Development
Ms. Jill Mayer
Senior Vice President of Human Resources
Dr. J. Stark Thompson Ph.D.
Consultant

Important FAQs about investing in Maxcyte from India :

What is Maxcyte share price today?

Maxcyte share price today stands at $4.30, Open: $4.40 ; Previous Close: $4.39 ; High: $4.48 ; Low: $4.25 ; 52 Week High: $5.55 ; 52 Week Low: $3.17. The stock opens at $4.40, after a previous close of $4.39. The stock reached a daily high of $4.48 and a low of $4.25, with a 52-week high of $5.55 and a 52-week low of $3.17.

Can Indians buy Maxcyte shares?

Yes, Indians can invest in the Maxcyte (MXCT) from India.

With INDmoney, you can buy Maxcyte at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Maxcyte at zero transaction cost.

How can I buy Maxcyte shares from India?

It is very easy to buy Maxcyte from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Maxcyte be purchased?

Yes, you can buy fractional shares of Maxcyte with INDmoney app.

What are the documents required to start investing in Maxcyte stocks?

To start investing in Maxcyte, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Maxcyte

Today’s highest price of Maxcyte (MXCT) is $4.48.

Today’s lowest price of Maxcyte (MXCT) is $4.25.

What is today's market capitalisation of Maxcyte

Today's market capitalisation of Maxcyte MXCT is 438.8M

What is the 52 Week High and Low Range of Maxcyte

  • 52 Week High

    $5.55

  • 52 Week Low

    $3.17

What are the historical returns of Maxcyte?

  • 1 Month Returns

    5.28%

  • 3 Months Returns

    5.02%

  • 1 Year Returns

    -4.36%

  • 5 Years Returns

    -58.03%

Who is the Chief Executive Officer (CEO) of Maxcyte

Mr. Maher Masoud is the current Chief Executive Officer (CEO) of Maxcyte.